Currently, there are 1.28B common shares owned by the public and among those 1.28B shares have been available to trade.
The company’s stock has a 5-day price change of -0.48% and 12.58% over the past three months. MDT shares are trading 16.86% year to date (YTD), with the 12-month market performance up to 9.72% higher. It has a 12-month low price of $75.96 and touched a high of $96.25 over the same period. MDT has an average intraday trading volume of 7.18 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.95%, 4.42%, and 8.65% respectively.
Institutional ownership of Medtronic Plc (NYSE: MDT) shares accounts for 85.01% of the company’s 1.28B shares outstanding.
It has a market capitalization of $119.73B and a beta (3y monthly) value of 0.80. The stock’s trailing 12-month PE ratio is 28.37, while the earnings-per-share (ttm) stands at $3.29. The company has a PEG of 4.33 and a Quick Ratio of 1.43 with the debt-to-equity ratio at 0.54. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.56% over the week and 2.14% over the month.
Earnings per share for the fiscal year are expected to increase by 4.87%, and 6.94% over the next financial year. EPS should grow at an annualized rate of 6.56% over the next five years, compared to -4.12% over the past 5-year period.
Looking at the support for the MDT, a number of firms have released research notes about the stock. Citigroup stated their Buy rating for the stock in a research note on March 04, 2025, with the firm’s price target at $92-$107. RBC Capital Mkts coverage for the Medtronic Plc (MDT) stock in a research note released on October 10, 2024 offered a Outperform rating with a price target of $105. Oppenheimer was of a view on August 21, 2024 that the stock is Perform, while UBS gave the stock Neutral rating on August 15, 2024, issuing a price target of $76- $90. Stifel on their part issued Hold rating on August 14, 2024.
